Efficacy and safety of long-term postpartum antiviral therapy in hepatitis B virus-infected mothers receiving prophylactic tenofovir disoproxil fumarate treatment
暂无分享,去创建一个
Yali Feng | Jinfeng Liu | Tianyan Chen | Yingli He | Lei Shi | N. Yao | Yage Zhu | Ying‐ren Zhao
[1] H. Xing,et al. Antiviral Therapy for Prevention of Perinatal Hepatitis B Virus Transmission Reduces the Incidence of Postpartum Hepatitis Flare , 2022, BioMed research international.
[2] Steven R. Martin,et al. Real‐world clinical and virological outcomes in a retrospective multiethnic cohort study of 341 untreated and tenofovir disoproxil fumarate‐treated chronic hepatitis B pregnant patients in North America , 2020, Alimentary pharmacology & therapeutics.
[3] C. Pan,et al. The safety of antiviral therapy and drug withdrawal for the prevention of mother‐to‐child transmission of HBV during pregnancy , 2020, Journal of medical virology.
[4] C. Coffin,et al. Hepatitis B and Pregnancy: Virologic and Immunologic Characteristics , 2020, Hepatology communications.
[5] S. Ahn,et al. An observational study on long‐term renal outcome in patients with chronic hepatitis B treated with tenofovir disoproxil fumarate , 2020, Journal of viral hepatitis.
[6] S. Belle,et al. Total Alanine Aminotransferase (ALT) Flares in Pregnant North American Women With Chronic Hepatitis B Infection: Results From a Prospective Observational Study , 2019, The American journal of gastroenterology.
[7] D. Cai,et al. [Impact of cessation of antiviral therapy at delivery on postpartum liver function in mothers with chronic hepatitis B virus infection]. , 2019, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.
[8] A. Garg,et al. Serum Creatinine Levels Before, During, and After Pregnancy , 2019, JAMA.
[9] Yang Ding,et al. Efficacy and safety of nucleos(t)ide analogues to prevent hepatitis B virus mother-to-child transmission in pregnant women with high viremia: real life practice from China , 2018, International journal of medical sciences.
[10] J. Lewis,et al. Incidence, determinants and outcomes of pregnancy‐associated hepatitis B flares: A regional hospital‐based cohort study , 2018, Liver international : official journal of the International Association for the Study of the Liver.
[11] Z. Wang,et al. Safety and efficacy of telbivudine in late pregnancy to prevent mother‐to‐child transmission of hepatitis B virus: A multicenter prospective cohort study , 2018, Journal of viral hepatitis.
[12] Ming Liu,et al. The characteristics and predictors of postpartum hepatitis flares in women with chronic hepatitis B , 2018, The American Journal of Gastroenterology.
[13] Zicheng Jiang,et al. Baseline Hepatitis B Virus Titer Predicts Initial Postpartum Hepatic Flare: A Multicenter Prospective Study , 2017, Journal of clinical gastroenterology.
[14] Thomas Berg,et al. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. , 2017, Journal of hepatology.
[15] F. Cao,et al. Hepatic flare after telbivudine withdrawal and efficacy of postpartum antiviral therapy for pregnancies with chronic hepatitis B virus , 2016, Journal of gastroenterology and hepatology.
[16] Yue Chen,et al. Effect of Peg‐interferon α‐2a combined with Adefovir in HBV postpartum women with normal levels of ALT and high levels of HBV DNA , 2015, Liver international : official journal of the International Association for the Study of the Liver.
[17] H. Khalili,et al. Tenofovir-induced nephrotoxicity: incidence, mechanism, risk factors, prognosis and proposed agents for prevention , 2014, European Journal of Clinical Pharmacology.
[18] S. Locarnini,et al. Anti‐viral therapy for prevention of perinatal HBV transmission: extending therapy beyond birth does not protect against post‐partum flare , 2014, Alimentary pharmacology & therapeutics.
[19] T. Skopek,et al. A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function , 2010, Nature Biotechnology.
[20] Z. Duan,et al. [The guidelines of prevention and treatment for chronic hepatitis B]. , 2005, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.